Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases. (2006)

First Author: Chalmers CR

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gut.2005.090571

PubMed Identifier: 16766770

Publication URI: http://europepmc.org/abstract/MED/16766770

Type: Journal Article/Review

Volume: 55

Parent Publication: Gut

Issue: 7

ISSN: 0017-5749